Lipocine Stock Price

0.0223 (2.87%)
Upgrade to Real-Time
Regular Market
Volume 186,844
Bid Price 0.7985
Ask Price 0.7993
News -
Day High 0.82


52 Week Range


Day Low 0.76
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lipocine Inc LPCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0223 2.87% 0.7993 14:56:16
Open Price Low Price High Price Close Price Prev Close
0.7844 0.76 0.82 0.777
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
530 186,844 $ 0.7841038 $ 146,505 - 0.708 - 1.89
Last Trade Time Type Quantity Stock Price Currency
15:00:47 95 $ 0.7993 USD


Draw Mode:

Lipocine Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 70.74M 88.50M 86.21M $ 16.14M $ -747.32k -0.01 -77.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 287.50k 3.50%

more financials information »

Lipocine News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LPCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.830.88760.7080.7635942363,595-0.0307-3.7%
1 Month1.041.110.7080.9095166477,493-0.2407-23.14%
3 Months1.23461.890.7081.36902,394-0.4353-35.26%
6 Months1.201.890.7081.24694,322-0.4007-33.39%
1 Year1.281.890.7081.26785,243-0.4807-37.55%
3 Years1.883.500.3011.431,530,378-1.08-57.48%
5 Years3.715.330.3011.561,059,520-2.91-78.46%

Lipocine Description

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.